menu search

Cingulate announces detailed trial results from phase 3 adult efficacy and safety trial of ctx-1301 (dexmethylphenidate) for adhd

CTx-1301 Demonstrated Clinically Meaningful Improvements in Permanent Product Measure of Performance (P...

September 11, 2023, 10:00 am

Chinook therapeutics to present updated data from zigakibart (bion-1301) phase 1/2 trial in patients with iga nephropathy (igan) at the 60th european renal association (era) congress

SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developmen...

June 12, 2023, 4:00 pm

Cingulate announces successful transfer of ctx-1301 (dexmethylphenidate) proprietary ptr™ manufacturing processes to societal cdmo

Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced C...

May 3, 2023, 10:45 am

Why is cingulate (cing) stock up 72% today?

Cingulate (NASDAQ: CING ) stock is on the rise Friday after releasing positive data concerning its ADHD treatment. The big news today is Cingulate's C...

February 24, 2023, 7:47 am

Cingulate initiates phase 3 study of lead asset ctx-1301, designed as a true entire active-day treatment for adhd

Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in Sa...

January 4, 2023, 11:45 am

Lion copper and gold closes spin out of option on butte valley porphyry copper-gold property, nevada

Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) reported that it has closed the previously announced deal to spin out its option on the Butte Valle...

April 7, 2022, 7:46 am

Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies

Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...

February 8, 2022, 12:20 pm

Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies

Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...

February 8, 2022, 12:20 pm

Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies

Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...

February 8, 2022, 12:20 pm

Lion copper and gold inks deal to spin out its butte valley property option in nevada

Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...

February 1, 2022, 11:38 am

Lion copper and gold inks deal to spin out its butte valley property option in nevada

Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...

February 1, 2022, 11:38 am

Lion copper and gold inks deal to spin out its butte valley property option in nevada

Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...

February 1, 2022, 11:38 am


Search within

Pages Search Results: